Cambridge Investment Research Advisors, Inc. Medpace Holdings, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 3,125 shares of MEDP stock, worth $970,718. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,125
Previous 3,230
3.25%
Holding current value
$970,718
Previous $1.33 Million
21.58%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MEDP
# of Institutions
617Shares Held
25.1MCall Options Held
42.8KPut Options Held
207K-
Black Rock Inc. New York, NY2.58MShares$801 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$791 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT909KShares$282 Million1.51% of portfolio
-
State Street Corp Boston, MA753KShares$234 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA628KShares$195 Million0.02% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $9.66B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...